← All organizations
Instituto do Cancer do Estado de São Paulo
Academic/HospitalWebsite ↗
Also known as: Fauze Maluf Filho | ICESP - HCFMUSP | Instituto do Cancer do Estado de Sao Paulo | Instituto do Cancer do Estado de São Paulo | Instituto do Câncer do Estado de São Paulo | Instituto do Câncer do Estado de São Paulo | Tiago Biachi
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2010Last known activity
Apr 10, 2025
Timeline
2000s
- Jun 1, 2008
Instituto do Cancer do Estado de São Paulo— Founded
Drugs by trial phase (58 distinct, 45 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Cancer Pain
- Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiotoxicity
- Colorectal Neoplasms
- Constriction, Pathologic
- Coronavirus Infections
- Esophageal Squamous Cell Carcinoma
- Esophageal Stenosis
- Head and Neck Neoplasms
- Heart Failure
- Infections
- Mouth Neoplasms
- Musculoskeletal Pain
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neuroendocrine Tumors
- Oropharyngeal Neoplasms
- Pancreatic Neoplasms
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Prostatic Neoplasms
- Severe Acute Respiratory Syndrome
- Shock
- Shock, Septic
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Vomiting
Recent trials (50)
- NCT06887621Sponsor investigatorPhase 2Apr 10, 2025
- NCT06887621Lead sponsorPhase 2Apr 10, 2025
- NCT06435286CollaboratorPhase 2Nov 1, 2024
- NCT06640283Sponsor investigatorPhase 2Nov 1, 2024
- NCT06640283Lead sponsorPhase 2Nov 1, 2024
- NCT06638931Lead sponsorPhase 2Jul 1, 2024
- NCT06638931Sponsor investigatorPhase 2Jul 1, 2024
- NCT06982274Lead sponsorPhase 2Oct 20, 2023
- NCT06982274OfficialPhase 2Oct 20, 2023
- NCT06034561Overall official - principal investigatorPhase 2Sep 30, 2023
- NCT06034561Lead sponsorPhase 2Sep 30, 2023
- NCT05816668Lead sponsorPhase 3Apr 30, 2023
- NCT05816668Reponsible party - principal investigatorPhase 3Apr 30, 2023
- NCT05816668Overall official - principal investigatorPhase 3Apr 30, 2023
- NCT05622136Reponsible party - principal investigatorPhase 2Jan 31, 2023
Details
- Founded
- Sao Paulo, BR Jun 1, 2008
- Last known activity
- Apr 10, 2025